2005
DOI: 10.1590/s1516-44462005000100018
View full text |Buy / Rent full text
|
Sign up to set email alerts
|

Abstract: Um problema grave na psiquiatria é a demora no diagnóstico correto e o conseqüente tratamento adequado das patologias. Talvez o problema mais grave seja em relação ao Transtorno Bipolar (TB). Muitas vezes, os pacientes são erroneamente diagnosticados e tratados como esquizofrênicos, devido aos episódios psicóticos; em outras, nas formas mais leves do transtorno, como deprimidos, devido ao não reconhecimento de alguns sintomas, como irritabilidade, impulsividade e hiperatividade. 1 Esta doença é um importante p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
0
1

Year Published

2015
2015
2020
2020

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 1 publication
(3 reference statements)
0
2
0
1
Order By: Relevance
“…8 The absence of any double-blind, placebo-or activecontrolled trial of pharmacotherapy for FEM clearly indicates a research gap and a need for such studies. In the research agenda, development of pharmacological treatments for early stages of BD should address symptom control, promotion of remission, and prevention of progression.…”
Section: Psychopharmacologicalmentioning
confidence: 99%
See 1 more Smart Citation
“…8 The absence of any double-blind, placebo-or activecontrolled trial of pharmacotherapy for FEM clearly indicates a research gap and a need for such studies. In the research agenda, development of pharmacological treatments for early stages of BD should address symptom control, promotion of remission, and prevention of progression.…”
Section: Psychopharmacologicalmentioning
confidence: 99%
“…4,5 This effect can be observed on a number of outcomes, including shortening of inter-episodic interval, persistence of subsyndromal symptoms, cognitive deficits, higher number of hospitalizations, emergence of medical and psychiatric comorbidities, increased suicide risk, worse social adjustment, and poor quality of life. [6][7][8][9][10] Moreover, treatment response also appears to change as a function of episode frequency, as both pharmacological agents (e.g., lithium, olanzapine) and psychosocial interventions (e.g., psychoeducation, cognitive-behavioral therapy) seem less effective in multiepisodic BD. 11,12 The clinical progression described above is hypothesized to be subserved by neurobiological changes, the so-called neuroprogression.…”
Section: Introductionmentioning
confidence: 99%
“…Trata-se de uma doença com alto grau de mortalidade, cujo risco de suicídio é trinta vezes maior do que outros transtornos (GAZELLE et al, 2005).…”
Section: Introductionunclassified